Daxor Research and Development Expenses 2010-2011 | DXR
Daxor research and development expenses from 2010 to 2011. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Daxor Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2011 | $3 |
| 2010 | $3 |
| 2009 | $3 |
| Daxor Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| 2011-03-31 | $1 |
| 2010-12-31 | $1 |
| 2010-09-30 | $1 |
| 2010-06-30 | $1 |
| 2010-03-31 | $1 |
| 2009-12-31 | $1 |
| 2009-09-30 | $1 |
| 2009-06-30 | $1 |
| 2009-03-31 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.045B | $0.000B |
| Daxor Corporation is a medical device manufacturing corporation with additional biotech services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $17.429B | 10.54 |
| Quest Diagnostics (DGX) | United States | $15.377B | 15.89 |
| DaVita (DVA) | United States | $12.061B | 14.98 |
| Encompass Health (EHC) | United States | $8.712B | 22.30 |
| Chemed (CHE) | United States | $8.709B | 26.99 |
| Elanco Animal Health (ELAN) | United States | $8.401B | 21.80 |
| Option Care Health (OPCH) | United States | $5.235B | 19.82 |
| RadNet (RDNT) | United States | $4.083B | 85.00 |
| Amedisys (AMED) | United States | $3.121B | 22.11 |
| LifeStance Health (LFST) | United States | $2.622B | 0.00 |
| Astrana Health (ASTH) | United States | $2.179B | 29.46 |
| Addus HomeCare (ADUS) | United States | $1.789B | 25.59 |
| U.S Physical Therapy (USPH) | United States | $1.603B | 42.90 |
| Pennant (PNTG) | United States | $0.680B | 35.94 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.481B | 0.00 |
| Atai Life Sciences (ATAI) | Germany | $0.316B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.027B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.015B | 0.00 |
| Ontrak (OTRK) | United States | $0.013B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.011B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.004B | 0.00 |